title: The effect of pulmonary-delivered insulin on blood glucose levels using two nebulizer systems.
authors.affiliation: Toxicology Research Laboratories, Lilly Research Laboratories, Eli Lilly and Company, Greenfield, Indiana 46140, USA.
authors.forename: R S
authors.initials: RS
authors.lastname: Pillai
authors.forename: B L
authors.initials: BL
authors.lastname: Hughes
authors.forename: R K
authors.initials: RK
authors.lastname: Wolff
authors.forename: J A
authors.initials: JA
authors.lastname: Heisserman
authors.forename: M A
authors.initials: MA
authors.lastname: Dorato
mesh_terms: D000280:Administration, Inhalation; D000818:Animals; D019540:Area Under Curve; D001786:Blood Glucose / Q000032:analysis / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005240:Feasibility Studies; D005260:Female; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage* / Q000493:pharmacokinetics; D008168:Lung / Q000187:drug effects / Q000648:ultrastructure; D008253:Macaca mulatta; D008297:Male; D009330:Nebulizers and Vaporizers